Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew Guggenhime currently holds 95,316 shares of FACET BIOTECH CORP (FACT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Guggenhime has been a net seller of FACT stock. They have purchased $0 and sold $12.0M worth of shares.
Andrew Guggenhime's most recent insider trade was on Sep 8, 2026, when they sold 7,155 shares at $60.36 per share.
Andrew Guggenhime serves as Executive at FACET BIOTECH CORP (FACT). They have executed 163 insider transactions totaling $12.0M over their tenure at the company.
Andrew Guggenhime holds the position of Executive at FACET BIOTECH CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Andrew Guggenhime has shown a selling trading pattern, with $0 in total purchases and $12.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Andrew Guggenhime was on Sep 3, 2024, when they sold $698.0K worth of PCVX shares. This transaction involved 6,337 shares at $110.15 per share.
Andrew Guggenhime currently owns 95,316 shares of FACET BIOTECH CORP (FACT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew Guggenhime's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew Guggenhime has 163 Form 4 filings on record as an insider at FACET BIOTECH CORP.
Set alerts for Andrew Guggenhime and 40,000+ other insiders.